Migraine Disorders Clinical Trial
— E-MigraOfficial title:
A 26-week Randomized Clinical Trial of an Electronic Headache Diary in Migraine Patients
This study aims to evaluate the usefulness of an app-based headache diary in episodic migraine patients. For this the investigators will conduct a randomized clinical trial with a crossover design, using the app-based diary and a traditional paper-based headache diary. The patients will use each diary for 13 weeks. The investigators will evaluate diary adhesion after each 13-week period, and also evaluate headache burden and prophylactic medication compliance at the beginning, at the crossover point, and at the end of the study, and acute headache medication use through diary records. The investigators will also evaluate user preference through a questionnaire at the end of the study.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | November 1, 2021 |
Est. primary completion date | October 2, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Patients with episodic migraine, diagnosed for more than 6 months. - Patients with at least 4 headache days per month and a maximum of 15 headache days per month. Exclusion Criteria: - Patients with major psychiatric illness. - Patients participating in another clinical trial. - Patients who do not meet diagnostic criteria for episodic migraine according to ICHD-3. - Illiterate patients or those who are unable to fill the records independently. - Patients with a previous history of filling in a headache calendar, in the 3 months prior to randomization. - Patients who do not use a cell phone with Android OS. - Patients who cannot read or write in Portuguese. |
Country | Name | City | State |
---|---|---|---|
Portugal | Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos | Matosinhos | Porto |
Lead Sponsor | Collaborator |
---|---|
Unidade Local de Saúde de Matosinhos, EPE |
Portugal,
Allena M, Cuzzoni MG, Tassorelli C, Nappi G, Antonaci F. An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain. 2012 Oct;13(7):537-41. doi: 10.1007/s10194-012-0473-2. Epub 2012 Jul 28. — View Citation
Baos V, Ester F, Castellanos A, Nocea G, Caloto MT, Gerth WC; I-Max Study Group. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes. Int J Clin Pract. 2005 Mar;59(3):281-6. — View Citation
Becker WJ, Findlay T, Moga C, Scott NA, Harstall C, Taenzer P. Guideline for primary care management of headache in adults. Can Fam Physician. 2015 Aug;61(8):670-9. Review. — View Citation
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14. — View Citation
Hundert AS, Huguet A, McGrath PJ, Stinson JN, Wheaton M. Commercially available mobile phone headache diary apps: a systematic review. JMIR Mhealth Uhealth. 2014 Aug 19;2(3):e36. doi: 10.2196/mhealth.3452. Review. — View Citation
Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003 Dec;12(8):963-74. — View Citation
Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, Jhingran P. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache. 2000 Mar;40(3):204-15. — View Citation
Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J. Diaries and calendars for migraine. A review. Cephalalgia. 2006 Aug;26(8):905-16. Review. — View Citation
Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004 Mar;13(2):299-310. — View Citation
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-8. Review. — View Citation
Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 Mar;27(3):193-210. Review. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diary compliance | To assess whether the compliance of migraine patients to the use of an electronic headache diary is superior to adherence to the paper diary. The quantification of adherence will be made in: 1.1.) % Of days per month of headache registration; and 1.2.) % of patients who abandon calendar registration at 13 weeks. | 6 months | |
Secondary | Patient Preference | Preference of the patient for one of the diaries measured through a questionnaire. | 6 months | |
Secondary | Quality of Life (HIT-6) | Comparison of the quality of life using data from HIT-6 evaluated at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Quality of Life (MSQ v2.1) | Comparison of the quality of life using data from MSQ v2.1 evaluated at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Quality of Life (WHOQOL-BREF) | Comparison of the quality of life using data from WHOQOL-BREF evaluated at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Incapacity Days | Comparison of the number of incapacity days using data from the diaries and from MiDAS evaluated at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Subjective Evaluation of the Number of Headache Days | Comparison of the patient's subjective evaluation of the number of headache days using data from questionnaires evaluated at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Number of Acute Headache Medication Use Days | Comparison of the number of acute headache medication use days using data from the diaries and questionnaires filled at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Prophylactic Medication Compliance | Comparison of the number of days of prophylactic medication noncompliance evaluated by questionnaire at the baseline, after using the electronic diary and after using the paper diary. | 6 months | |
Secondary | Emergency Department Visits | Comparison of the number of emergency department visits evaluated by data collected from the diaries and a questionnaire filled at the baseline, after using the electronic diary and after using the paper diary. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01432379 -
BOTOX® Prophylaxis in Patients With Chronic Migraine
|
||
Completed |
NCT04084314 -
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
|
Phase 4 | |
Recruiting |
NCT05048914 -
Migraine Abortive Treatment
|
||
Completed |
NCT03662295 -
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
|
||
Completed |
NCT02766517 -
Biomarker Study in Participants With Migraine
|
Early Phase 1 | |
Completed |
NCT00963937 -
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
|
Phase 3 | |
Not yet recruiting |
NCT03632928 -
Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
|
||
Completed |
NCT02559895 -
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
|
Phase 3 | |
Completed |
NCT01435941 -
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
|
N/A | |
Completed |
NCT00743015 -
Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
|
Phase 1 | |
Completed |
NCT01376141 -
Drug Use Investigation for IMIGRAN Tablet
|
N/A | |
Completed |
NCT02183688 -
Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients
|
Phase 3 | |
Completed |
NCT06061588 -
"Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches"
|
N/A | |
Completed |
NCT03588364 -
The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine
|
N/A | |
Completed |
NCT04091321 -
Association Between Chronic Headache and Back Pain With Childbirth
|
||
Completed |
NCT00385008 -
TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
|
Phase 3 | |
Active, not recruiting |
NCT05888298 -
Proximal and Distal Approach GON RFT in Migraine
|
N/A | |
Completed |
NCT03435185 -
Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients
|
N/A | |
Recruiting |
NCT06459635 -
Migraine Attack Pain Phase Prediction Study
|
||
Completed |
NCT02565186 -
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
|
Phase 3 |